Advanced TB Diagnostics Research Education
A new technology entitled GeneXpert was deemed a ‘game-changer’ in the world of TB diagnostics. To reduce the burden and mortality of TB, it is imperative to not only have advanced technologies to detect TB bacteria, but to also have experts that know how to use the new technology. In 2016, USAID TB CARE II funded the attendance of 11 people from select low or middle‐income countries to attend the McGill Summer Institute in Infectious Diseases and Global Health to take courses on Advanced TB Diagnostic Research.
|18 Nov 2016 15:51|
Multi-Drug Resistant TB
In 2014, approximately 480,000 people developed MDR-TB. 3.3% of new cases and 20% of previously treated patients develop MDR-TB. It was estimated that only 41% of cases were notified that they had MDR-TB in 2014. In low and middle income countries, access to quality TB services is often limited. Since the beginning of TB CARE II in 2010, TB CARE II has worked to decrease MDR-TB.
|18 Nov 2016 15:49|
Germicidal Ultra Violet Meeting
On October 10-11, 2016, delegates from twenty, primarily low- and middle-income countries gathered at the Council for Scientific and Industrial Research (CSIR) conference center in Pretoria, South Africa.
|16 Nov 2016 16:32|
TB in Mines
In 2015, USAID TB CARE II project began an initiative to address TB in miners in the Southern African Region. The overall objective is to improve detection and management of TB and other co-morbidities among the mine workers and their families. This would also help to control the spread of TB and reduce new incidences of TB.
|21 Nov 2016 10:34|